Modelled decline in FEV1 related to responder definition and treatment group
| Fluticasone propionate | Placebo | |||
|---|---|---|---|---|
| n | ΔFEV1 ml/year (95% CI) | n | ΔFEV1 ml/year (95% CI) | |
| Callahan responder | 29 | 50 (20 to 80) | 24 | 64 (33 to 96) |
| Callahan non-responder | 213 | 47 (37 to 57) | 206 | 55 (45 to 66) |
| ATS responder | 36 | 55 (29 to 80) | 30 | 67 (40 to 95) |
| ATS non-responder | 206 | 46 (36 to 56) | 200 | 55 (44 to 66) |